ARCH Venture Partners

Last activity: 15.05.2024
Probably Closed
Invests in categories: HealthTechPlatformTechnologyDrugDevelopmentBioTechProductMedTechResearchCare
Location: United States, Illinois, Chicago
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Series B; Series C; IPO; Grant

Portfolio 202

DateNameWebsiteTotal RaisedLocation
09.03.2024Basking Bi...baskingbiosciences.com$60.4MUnited Sta...
09.03.2024Moonwalk B...moonwalk.bio$57M-
09.02.2024Lifordi Im...lifordi.com--
08.11.2023SciNeuro P...scineuro.com-United Sta...
08.11.2023Areteia Th...areteiatx.com$425MUnited Sta...
08.11.2023Ingredient...ingredientwerks.com-United Sta...
08.11.2023Paradigm H...paradigm.inc$203MUnited Sta...
08.11.2023Earth Opti...earthoptics.com$37.9MUnited Sta...
08.11.2023Rippl Careripplcare.com$35MUnited Sta...
08.11.2023Akamis Bioakamisbio.com--
Show more

Persons 4

DateFirst NameLast NameTitleLinkedInLocation
-KristinaBurowManaging D...linkedin.c...-
-SteveGillis, Ph...Managing D...linkedin.c...-

News 70

27.02.2024Managing Director Kristina Burow named to STAT’s 2024 STATUS list alongside other top leaders shaping the industry-
01.11.2023With ARCH funding, Gate Biosciences finds new way to attack diseases-
21.09.2023Four ARCH-backed companies named to Endpoints 11 list of most exciting biotech startups in 2023-
14.07.2023ARCH Venture Partners Announces Appointment of Kent Rogers as Venture Partner-
25.05.2023ARCH Venture Partners Announces Appointment of Kevin Hrusovsky as Venture Partner-
23.05.2023ARCH Venture Partners Announces Appointment of Jami Rubin as Venture Partner-
25.04.2023ARCH leads Series A for Orbital, supporting research to unleash full potential of RNA medicines-
06.04.2023ARCH Venture Partners Announces Appointment of Brian Cuneo as Senior Partner-
07.03.2023ARCH leads Volastra $60 million financing round-
27.01.2023The New York Times profiled ARCH-backed Paradigm, which aims to simplify clinical trials-
Show more

Mentions in press and media 133

15.05.2024Most-Active US Investors: Sequoia, Khosla, General Catalyst Lead Strong Pack In April9 Shares Email Facebook Twitter LinkedIn This is a monthly feature that runs down some of the most-active investors in U.S.-based companies, looks at some of their most interesting investments, and includes some odds and ends of who spent w...
30.04.2024Rippl acquires KintoRippl, a Seattle, WA-based dementia-focused specialty care provider, announced it has acquired Kinto, a Boston, MA-based provider of an AI-enabled dementia caregiver support platform. The amount of the deal was not disclosed. This combinati...
25.04.2024Xaira Therapeutics: A Billion-Dollar Bet on AI Drug DiscoveryIn the fast-paced world of tech and biotech, Xaira Therapeutics emerges as a powerhouse with a massive $1 billion in funding. Led by CEO Marc Tessier-Lavigne, a former Stanford president and Genentech chief scientific officer, Xaira is read...
24.04.2024Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugsAdvances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of...
12.04.2024Most-Active US Investors: General Catalyst Tops March’s List3 Shares Email Facebook Twitter LinkedIn This is a monthly feature that runs down some of the most-active investors in U.S.-based companies, looks at some of their most interesting investments, and includes some odds and ends of who spent w...
03.04.2024From generative chemistry to computational astrophysics, startups employ new methods to fight cancerHere are a few startups in the cancer space that made headlines recently The recent revelation of Princess Kate Middleton’s battle with cancer has sent ripples across the globe, reminding us that this disease knows no boundaries of status o...
02.04.2024Autism Impact Fund closes $60M first fund and broadens its scopeMillions of people around the world are affected by autism spectrum disorder (ASD). Both as kids and later in life, these individuals and their families need better detection, treatment and support solutions that will help them live with au...
02.02.2024ARCH Venture Partners is raising $3 billion for a life sciences fundARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund. The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake...
25.07.2023Molecular farming: IngredientWerks grows heme protein in corn at ‘unprecedented low cost’Molecular farming startup IngredientWerks has genetically engineered corn crops to express high levels of bovine myoglobin in a process it claims can scale at a fraction of the cost of precision fermentation. A heme-binding protein found in...
11.04.2023Recuro Health Closes $47 Million Series B Financing Led by ARCH Venture Partners, Advancing Innovative Virtual-First Care ServiceDALLAS–(BUSINESS WIRE)–April 11, 2023– Recuro Health (Recuro), an integrated digital health solutions company designed to transition the U.S. healthcare system from a reactive, disease-focused model to a proactive care approach, today annou...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In